The growth factor receptor bound proteins 7, 10 and 14 (Grb7, Grb10 and Grb14) form a family of mammalian adaptor proteins that play important roles mediating the transmission of signals from tyrosine kinase receptors and nonreceptor tyrosine kinases by coupling protein complexes to attain cellular responses [1] [2] [3] [4] [5] [6] . These proteins are phylogenetically related to the Caenorhabditis elegans Mig10 protein, which is involved in the regulation of embryonic neural cell migration [7, 8] . They all share significant sequence homology and a well-conserved modular structure divided into several domains: a proline-rich (PR) domain in the N-terminal, a central GM region (for Grb and Mig10) comprising a Ras-associating (RA) domain, a pleckstrin homology (PH) domain and a BPS domain (for between PH and SH2); and finally a Src homology 2 (SH2) domain located in the C-terminal [1] [2] [3] 5] .
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[10]. In tumor cells, coexpression of Grb7 with the tyrosine kinase receptor ErbB2, and its natural occurring variant Grb7V lacking the SH2 domain, contribute to tumor cells invasiveness and metastasis formation [11] [12] [13] . In addition, Grb7 also plays important roles in cell proliferation [14, 15] , cell adhesion [16] and tumorassociated angiogenesis [15, 17] . Several isoforms of the human Grb10 generated by alternative splicing have been described, including hGrb10a, hGrb10b and hGrb10c [2] , the hGrb10c isoform being the longest [18, 19] . The hGrb10a isoform is shorter and lacks a 46 amino acids long section corresponding to the PH domain [19, 20] . The hGrb10b isoform differs from the hGrb10a isoform in the 5 0 -UTR and in the 5 0 coding region, and although has an intact PH domain as the hGrb10c isoform, it has a shorter N-terminal region [21] . These isoforms differ in their expression pattern, which seems to be tissuespecific [22, 23] . Although Grb10 has been found to interact with different tyrosine-kinase receptors including the epidermal growth factor receptor (EGFR) [1] , EphB1/ELK [24] , platelet-derived growth factor receptor [21] and vascular endothelial growth factor receptor [25] , and nonreceptor tyrosine kinases including Tec [26] and Bcr-Abl [27] , its most important described role is to bind with high affinity to the insulin receptor [19, 28] and the insulin-like growth factor 1 receptor (IGF-1R) [20, [29] [30] [31] [32] [33] causing the inhibition of these receptors upon ligand stimulation. Besides, Grb10 has been found to interact with the ubiquitin ligase Nedd4 [34] triggering the internalization and degradation of the IGF-1R [35] .
Grb14 was first identified in human breast epithelial cells [36] . This adaptor protein was also found to inhibit the insulin receptor and IGF-1R after insulin stimulation mediating the coordinated downregulation of the receptors [37] . This interaction was mediated by the BPS domain of Grb14 inhibiting the catalytic activity of the receptor, process that was enhanced by the SH2 domain of the adaptor protein [38, 39] . The GRB14 gene is overexpressed in breast and prostate tumors [36, 40] , and several mutations occurring with high frequency in human colorectal cancers have been described [41] .
Calmodulin (CaM) is a ubiquitous Ca 2+ -receptor protein in all eukaryotic cells that transduces intracellular Ca 2+ signals generated by a variety of biological effectors (e.g. growth factors, hormones, neurotransmitters) or physical stimulus (e.g. mechanical, light, temperature) regulating hundreds of enzymes and nonenzymatic proteins implicated in the control of multiple cellular functions [42] [43] [44] [45] [46] . In addition, Ca 2+ -free CaM (apo-CaM) is also able to regulate a variety of target proteins [47] . We have previously demonstrated in vitro and in living cells Ca 2+ -dependent binding of CaM to human Grb7 and identified its CaM-binding domain (CaM-BD) located at the proximal region of the PH domain comprising the sequence 243 RKLWKRFFCFLRRS 256 [17] . The deletion of this site affects Grb7-mediated cellular functions including its nuclear translocation, cell attachment, cell migration, tumor growth and tumor-associated angiogenesis [15] [16] [17] 48] . In this report, we demonstrate that Grb10 and Grb14 are also Ca 2+ -dependent CaM-binding proteins and identify the location of their CaM-BDs using deletion mutants. 
Materials and Methods

Reagents
Vectors preparation
The pCR3/FLAG-Grb7 vector was kindly donated by S. Tanaka (Kyushu University, Japan), and its open reading frame (ORF) was amplified by polymerase chain reaction (PCR) as previously described [17] using the following oligonucleotides: forward primer 5 0 -GAT GAC GAT CAT ATG GAG CCG GAT CTG TCT CCA CCT CAT C-3 0 containing a NdeI restriction site (underlined) and reverse primer 5 0 -GCC AGT CCA CGC TCG AGT CAG AGG GCC ACC CGC GTG CAG C-3 0 , containing a XhoI restriction site (underlined). The PCR product was subcloned into the bacterial expression vector pET-14b to obtain pET-Grb7. Additionally, the CaM-BD (residues 243-256) deletion mutant denoted Grb7Δ was generated by mutagenesis using the ExSite TM mutagenesis kit, the vectors pCR3/FLAG-Grb7 and pET-Grb7 as templates and the following oligonucleotides: forward 5 0 -TCC TGA ACC CCG CAG CTG CAG AAA GCC CTG-3 0 and reverse 5 0 -GGC GTC TAT TAC TCC ACC AAG GGC ACC TCT AAG-3 0 . Alternatively, EcoRI and XhoI restriction enzymes were used to subclone FLAG-Grb7 and FLAG-Grb7Δ into pcDNA3.1, yielding the pcDNA3/FLAG-Grb7 and pcDNA3/FLAG-Grb7Δ vectors. The pCDNA3/Grb10c-HA vector was kindly provided by S. Gioretti-Peraldi (INSERM, Faculty of Medicine, Nice, France) and was used as a template to obtain pcDNA3/Grb10Δ-HA with the ExSite TM mutagenesis kit and the following oligonucleotides: forward 5 0 -GCA TGT [17] , and in the case of Grb10Δ1 and Grb10Δ3 using a software for predicting CaM-BDs (freely available at http://calcium.uhnres.utoron to.ca). Each single mutant was constructed using two PCR reactions, and directional ligation (subcloning) of resulting amplicons to pcDNA3. PCR reactions were done using Vent (New England Biolabs, Ipswich, MA, USA) polymerase to generate high fidelity blunt-ended amplicons, and pcDNA3-Grb10c-HA as a template, to allow subcloning in the same plasmid backbone. Primers for the first PCR were designed to generate a Grb10Δ1Δ2 and Grb10Δ2Δ3 were constructed following the same strategy but using a precedent deletion mutant backbone as a template for second rounds of PCR and ligation. The pRc/CMV/Grb14-FLAG vector was kindly donated by R. J. Daly (Monash University, Vic., Australia) and the pRc/CMV/Grb14Δ-FLAG vector was prepared amplifying the ORF of Grb14 using pRc/CMV/Grb14-FLAG as a template and the forward primer 5 0 -ATG ACC ACT TCC CTG CAA GAT G-3 0 . The PCR product was cloned into pMOSBlue plasmid and used as a template for PCR-aided mutagenesis using the forward primer 5 0 -GGT TTA TAT TTT TCT ACT AAA GGA AC-3 0 and the reverse primer 5 0 -TCC CTG TTC TTT CGC ATG TAA GA-3 0 . The PCR product was purified and religated in the pMOSBlue vector. Finally, the Grb14Δ insert was subcloned into the pRC/CMV/FLAG vector using the NdeI and EcoRI restriction enzymes. Vectors replication was performed in transformed Escherichia coli DH5a grown in Luria-Bertani broth with 0.1 mgÁmL À1 ampicillin. The isolation of the vectors was performed following the low-copy number procedure of the Genopure plasmid maxi kit. 
Cells culture
Cells transfection
The HEK293 cells were transfected with the following plasmids: pcDNA3.1 (empty vector), pcDNA3/FLAG-Grb7, pcDNA3/FLAG-Grb7Δ, pCDNA3/Grb10c-HA, pCDNA3/ Grb10cΔ1-HA, pCDNA3/Grb10cΔ2-HA, pCDNA3/ Grb10cΔ3-HA, pCDNA3/Grb10cΔ1Δ2-HA, pCDNA3/ Grb10cΔ2Δ3-HA, pRc/CMV/Grb14-FLAG and pRc/ CMV/Grb14Δ-FLAG with the calcium phosphate method as described [17] or the LipofectamineÒ 2000 method following the instructions of the manufacturer.
Electrophoresis and western blot
Proteins were electrophoretically separated in 5-20% (w/v) polyacrylamide gradient slab gels in the presence of 0.1% (w/v) SDS at pH 8.3 [49] during 16-17 h at 6 mA. Proteins were electrotransferred from the gels to PVDF membranes for 2 h at 400 mA in a buffer containing 48 mM Tris-base, 36.6 mM L-glycine, 0.04% (w/v) SDS and 20% (v/v) methanol (TGSM buffer). Proteins were fixed with 0.2% (v/v) glutaraldehyde in 10 mM Tris-HCl (pH 8) and 150 mM NaCl (TBS buffer) for 10 min; and transiently stained with a 0.1% (w/v) Fast Green FCF solution in 50% (v/v) methanol and 10% (v/v) acetic acid to verify the regularity of the transfer procedure. The membranes were blocked with 5% (w/v) BSA or 5% (w/v) fat-free powdered milk according to the instructions of the antibodies' manufacturers in TBS containing 0.1% (v/v) Tween-20 (TBS-T buffer) and incubated overnight at 4°C using a 1/2000 dilution of the corresponding primary antibody. Membranes were incubated thereafter for 1 h at room temperature using a 1/ 5000 dilution of the appropriate secondary antibody coupled to horseradish peroxidase. The positive bands were developed using the ECL reagents following instructions from the manufacturer.
Calmodulin-affinity chromatography
Ca 2+ -dependent CaM-affinity chromatography was performed as previously described [17] . Briefly, cells were washed twice with cold PBS (130 mM NaCl, 2.7 mM KCl, 11.5 mM sodium/potassium phosphate pH 7.4) and resuspended in a buffer containing 20 mM Hepes-NaOH (pH 7.5), 150 mM NaCl, and the protease inhibitor cocktail supplemented with freshly prepared 1 mM PMSF. The cells were sonicated on ice for 5 min with 15 s on/off pulses and centrifuged at 100 000 g for 30 min at 4°C. An aliquot of the supernatant was kept and processed by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate (SDS/PAGE) and western blot to have a positive control for input in the column. CaCl 2 was added to the rest of the supernatant at a final concentration of 100 lM and the sample was passed through a 1-2 mL bed volume CaM-Sepharose 4B column previously equilibrated with 25 mM Hepes-NaOH (pH 7.5), 135 mM NaCl, 100 lM CaCl 2 , and the protease inhibitor cocktail supplemented with freshly prepared 1 mM PMSF (Ca 2+ -buffer). After extensively washing with the same buffer, 0.5 mL fractions were collected before and after elution with a buffer containing 25 mM Hepes-NaOH (pH 7.5), 135 mM NaCl, 2 mM EGTA, and the protease inhibitor cocktail supplemented with freshly prepared 1 mM PMSF (EGTA-buffer).
The proteins in the fractions were precipitated with 10% (w/v) TCA and processed by SDS/PAGE and western blot as previously described.
Calmodulin binding to peptides upon addition of different calcium concentrations
Peptides were tagged with the fluorescent dye TAMRA. The binding of the tagged peptides to CaM was followed by fluorescence anisotropy in a medium of known changing free Ca 2+ concentrations. Exhaustive description of the methodology used was previously described [50] .
Results
Our laboratory previously described the presence of a CaM-BD in hGrb7 comprising the sequence 243 RKLWKRFFCFLRRS 256 located in the proximal region of the PH domain, and found that this adaptor protein was able to bind CaM in a Ca 2+ -dependent manner both in vitro and in living cells. To study the functionality of the CaM-BD of Grb7, we prepared a deletion mutant named Grb7Δ lacking the CaM-BD, and diverse techniques were used to ascertain its inability to bind CaM [17] .
Sequence analysis of Grb10 and Grb14 in several species showed that they have significant sequence homology and a well-conserved molecular structure with that of Grb7. When we compared the CaM-BD of hGrb7 with the sequences of hGrb10b/hGrb10c and hGrb14, we observed significant homology with the segments 246 (Table 1) . To study whether Grb10 and Grb14 are also CaMBPs as Grb7, we generated deletion mutants lacking the indicated segments, respectively, denoted by Grb7Δ, Grb10Δ and Grb14Δ. The expression of the wild-type proteins and their respective deletion mutants in transfected HEK293 cells show the expected increase in electrophoretic mobility of the mutants (Fig. 1A) . The cytosolic fractions of HEK293 cells transiently transfected with pcDNA3/Grb10c-HA or pcDNA3/FLAG-Grb14 were applied to a CaMSepharose 4B column equilibrated with a buffer containing Ca 2+ . After extensive washing with the Ca 2+ buffer, the bound proteins were eluted with an EGTAcontaining buffer. We also processed an aliquot of the cytosolic fraction as a positive control. The different fractions were separated by SDS/PAGE, transferred to PVDF and probed with specific antibodies. Figure 1B shows that both wild-type Grb10 and Grb14 were detected in the EGTA-eluted fractions, as was the case for wild-type Grb7, suggesting Ca 2+ -dependent bind to CaM. Once we identified the three Grb7 family members as CaM-BPs (Ref. [17] and Fig. 1B) , and as the sequence homology of the putative CaM-BDs of the three proteins were notorious (Table 1) , we tested whether the mutants lost their ability to bind CaM. We prepared cytosolic fractions of cells transiently transfected with pcDNA3/FLAG-Grb7Δ, pcDNA3/ Grb10Δ-HA or pcDNA3/FLAG-Grb14Δ and subjected them to Ca 2+ -dependent CaM-affinity chromatography as previously described. We determined the comparative behavior of the three deletion mutants in the column. Western blot analysis demonstrated that although Grb10Δ and Grb14Δ lost in part the ability to bind CaM when compared with their wildtype counterparts, they still had, particularly Grb10, significant CaM-binding capacity. In contrast, the deletion mutant Grb7Δ almost completely lost this ability (Fig. 1B) . Identical amino acids are indicated as dots, conserved substitutions as capital letters and nonconserved substitutions as lower case letters. CaM-BD, calmodulin-binding domain. The sequence identity of the CaM-BD and the whole protein are compared to human Grb7. The homologous CaM-BD sequence of the Mig10 protein from C. elegans is also included. The human Grb10a isoform lacks the region of the pleckstrin homology domain where the CaM-BD is located due to alternative splicing (N/A).
Fig. 1. Isolation of the three Grb7 family members by Ca
2+
-dependent CaM-affinity chromatography and effect of deleting the proposed CaM-BDs. (A) FLAG-tagged Grb7, HA-tagged Grb10 and FLAG-tagged Grb14 were transfected in HEK293 cells and their expression patterns determined by western blot using anti-Grb7, anti-HA and anti-Grb14 antibodies to detect FLAG-tagged Grb7 and Grb7Δ, HA-tagged Grb10 and Grb10Δ, and FLAG-tagged Grb14 and Grb14Δ, respectively. (B) FLAG-tagged Grb7, FLAG-tagged Grb14, HA-tagged Grb10, and their corresponding CaM-BD deletion mutants were transfected in HEK293 cells and their cytosolic fractions were processed by Ca 2+ -dependent CaM-affinity chromatography. After loading, the columns were extensively washed (W) with the Ca 2+ -buffer to ascertain the absence of unattached proteins. The EGTA-eluted fractions were processed by SDS/PAGE and western blot using anti-Grb7, anti-HA and anti-Grb14 antibodies to detect FLAG-tagged Grb7 and Grb7Δ, HA-tagged Grb10 and Grb10Δ, and FLAG-tagged Grb14 and Grb14Δ, respectively. Samples of the cytosolic fractions (CF) were included to ascertain the positive detection of the proteins.
To exclude that the adaptor proteins were piggyback bound to other CaM-BPs present in the preparations, we decided to estimate the binding and affinity of peptides corresponding to the identified CaM-BDs of Grb7, Grb10 and Grb14 to CaM. We used a new technique based on fluorescence polarization to describe the binding affinity of CaM for its target, as well as the minimum number of Ca 2+ bound to CaM to achieve efficient binding [50, 51] . Peptides corresponding to the CaM-BD of Grb7, and the homologous sequences of Grb10 and Grb14 tagged with the fluorescent probe TAMRA ( Fig. 2A) were assayed by fluorescent polarization of the CaM/peptide target interaction. We used a titration matrix in which both Ca 2+ and CaM concentrations were changed to determine the minimum number of Ca 2+ bound to CaM that was required for the interaction to occur with efficiency, as well as the apparent association and dissociation constants (K' a and K' d ) [50, 51] . Figure 2B shows the apparent dissociation constants (K' d ) of the fluorescent target peptides corresponding to the CaM-BD of Grb7, Grb10 and Grb14 when they bind to CaM as a function of the Ca 2+ concentration. The peptide corresponding to the CaM-BD of Grb7 presented higher affinity for CaM (as given by a lower K' d ) than the Grb14 peptide, while the affinity for CaM of the peptide corresponding to the potential CaM-BD of Grb10 was even lower than the latter.
CaM is able to bind up to four Ca 2+ , and the association constants of Ca 2+ to the different binding sites were used to obtain the apparent association constant (K' a ) of the peptides when bound to CaM in the absence of Ca 2+ and at different Ca 2+ saturations, as described in Table 2 for apo-CaM (A), CaM-Ca
2+ (E). With this information, it was determined the minimum number of Ca 2+ required to generate a conformational change in CaM to trigger effective binding to the peptides. In all cases, we found that this change occurred when a single Ca 2+ was bound to CaM, but in the case of the Grb7 peptide the affinity further increased upon additional Ca 2+ binding sites were saturated. Overall, these experiments confirmed that all the Grb7 family members are CaM-BPs and that the identified CaM-BD sequences are essential or contributed to Ca 2+ -dependent CaM binding. However, their relative affinities for CaM were different, resulting in the following sequence: Grb7 > > Grb14 > Grb10.
Since Grb10Δ showed significant residual capacity to bind CaM (Fig. 1A) , we searched for additional site(s) that could contribute to CaM binding. Although with low scores, we identified two additional sites with the sequences 246   RKNYAKYEFFKN   257   and   387   RTCWMTAFRLLK 398 . We prepared additional Grb10 deletion mutants lacking these new sites, denoted, respectively, Grb10Δ1 and Grb10Δ3; and assigning to the original mutant lacking the site 304 KKSWKKLYVCLRRS 317 used in Fig. 1 , that has higher homology to the CaM-BD of Grb7, the new name Grb10Δ2. In addition, we prepared the double deletion mutants Grb10Δ1Δ2 and Grb10Δ2Δ3. Figure 3A shows the expression pattern of this battery of Grb10 deletion mutants in transfected HEK293 cells, where a slight increase in electrophoretic mobility was apparent as expected, with the lowest mobility change corresponding to Grb10Δ3. We then determined the ability of all these mutants to interact with CaM using Ca 2+ -dependent CaM-affinity chromatography. Figure 3B shows that Grb10Δ1, and particularly Grb10Δ3, strongly decreased or lost, respectively, the capacity to bind CaM, as compared to Grb10Δ2. Similar results were found using the double deletion mutants Grb10Δ1Δ2 and Grb10Δ2Δ3 as expected.
Discussion
The mammalian Grb7 protein family formed by Grb7, Grb10 and Grb14 shares a conserved structure with high sequence homology [1] [2] [3] [4] [5] [6] . We have previously described human Grb7 and its variant Grb7V as CaM-BPs that bind CaM in a Ca 2+ -dependent manner both in vitro and in living cells [17] . In this work, we aimed to test whether the other members of the Grb7 family, Grb10 and Grb14, were also able to interact with CaM. As shown in Table 1 in hGrb14. We demonstrated using CaM-affinity chromatography that both hGrb10c and hGrb14 were able to bind CaM in a Ca 2+ -dependent manner. The fact that the Grb10 and Grb14 deletion mutants in these domains did not completely lose their ability to bind CaM suggested the possibility of alternative or additional CaM-BDs present in these proteins.
We have run in silico CaM-BD prediction and no other amphiphilic a-helix domain or any potential IQ motif were found in these proteins. In contrast to Grb7, where direct interaction with CaM was detected in vitro by CaM-affinity chromatography, CaM-overlay experiments and in living cells by FRET [17] ; at first, we could not discard that Grb10 and/or Grb14 could be piggy-back bound to unidentified CaM-BPs during the chromatographic process. To determine whether the proposed sequences had the capacity to bind CaM, we determined the binding and affinity of fluorescenttagged peptides corresponding to the CaM-BDs of hGrb7, hGrb10c and hGrb14 to CaM in the presence of different concentrations of Ca 2+ . Despite the high homology sequence shown between the three Grb7 protein family members, the affinity of these peptides for CaM was different, being the CaM-BD of Grb7 the one presenting the highest affinity while the one corresponding to the CaM-BD of Grb10 showed the lowest one, suggesting that structural differences might be found in these domains. As it has been previously described, several isoforms of hGrb10, generated by alternative splicing, have been identified, including hGrb10a, hGrb10b and hGrb10c [2] . They basically differ in their PH domain, where the CaM-BD is located. The hGrb10b and hGrb10c isoforms show high homology sequence between their putative CaM-BDs and the one of hGrb7 (Table 1) , whereas, the hGrb10a isoform lacks the segment harboring the sequence corresponding to the CaM-BD present in the other isoforms.
Typical CaM-BDs form basic amphiphilic a-helixes with basic and hydrophobic residues exposed at opposite sides of the helix [52] . Although in the predicted helical projections of the CaM-BDs of hGrb7, hGrb10b/hGrb10c and hGrb14, there is a noticeable segregation of basic and hydrophobic amino acids at opposite sides of all the helixes, the helix corresponding to the CaM-BD of Grb7 is the one showing a more uniform distribution, followed by the one corresponding to the CaM-BD of Grb14 and in lesser extent the one corresponding to the CaM-BD of hGrb10b/hGrb10c. This suggests that the CaM-BD of Grb7 would be the one presenting higher affinity for CaM, followed by the CaM-BDs of Grb14 and Grb10 as our results show. Crystallographic studies of the resolved PH domain of hGrb10b, where the CaM-BD is located, have shown that it is structured as a b-strand within a b-sheet [53] instead of an a-helix. This could be the reason why the affinity of the peptide corresponding to the CaM-BD of Grb10 shows the lowest affinity for CaM, as compare to the other Grb7 family members. The lack of crystallographic structures of the whole proteins, however, prevents us to establish whether or not the identified CaMBDs form a-helixes or not in its native forms. Nevertheless, in the case of Grb10, our results show that two additional sites, upstream and downstream of the canonical CaM-BD with sequence similarity to the CaM-BD of Grb7, play an essential role in CaM binding, as its absence drastically impairs Ca 2+ -dependent CaM binding. We could not identify in Grb14 additional sites with high score to be potential CaM-BD, although it cannot be discarded its existence due to the intrinsic uncertainty of the predicting software. Yet, we cannot exclude the existence in this protein of other accessory site(s) contributing to CaM binding. It is likely that conformational changes in the structure of these mutant proteins could contribute to the loss of their CaM-binding capacity.
As we have previously described, the minimum number of Ca 2+ bound to CaM required to induce an effect depends on the target protein and might vary from protein to protein, offering extra regulatory mechanisms [43, 47, 51, 54] . We found specific recognition of CaM for the CaM-BD peptides of Grb7, Grb10 and Grb14, when CaM had a single Ca 2+ bound, suggesting that although the affinity for CaM is different, the recognition mechanism appears to be very similar. Nevertheless, in the case of Grb7, the affinity for CaM increased upon binding of the second Ca 2+ (Table 2 ). In contrast, using an analogous approach, it was found that a peptide corresponding to the CaM-BD of the EGFR, also previously described by our laboratory as a CaM-BP [55] [56] [57] , presented the highest affinity for the Ca 2+ -CaM complex when 4 Ca 2+ were bound to CaM [51] .
Future work should be performed to determine the functional roles of the identified CaM-BDs of Grb10 and Grb14. As the different Grb10 isoforms differ in their expression pattern in a tissue-specific manner [23] , it would be interesting to study whether there is connection between this differential expression pattern and the effect that CaM could play regulating the isoforms that contain a CaM-BD (hGrb10b, hGrb10c) in contrast to the hGrb10a isoform lacking this domain.
